Literature DB >> 14592665

Induction of MIC-1/growth differentiation factor-15 following bile duct injury.

Leonidas G Koniaris1.   

Abstract

Macrophage inflammatory peptide-1 (MIC-1)/growth/differentiation factor-15 (GDF-15) is a divergent member of the transforming growth factor-beta superfamily cloned by others and us. MIC-1/GDF-15 is expressed in the liver, breast, and colon. Studies have demonstrated a growth-inhibiting effect of MIC-1/GDF-15 on colon and breast cancer cell lines in vitro and on tumor growth in vivo. We previously reported that MIC-1 expression is rapidly induced after a wide variety of murine acute and chronic liver injuries including aniline dye administration. I hypothesized, therefore, that MIC-1/GDF-15 may be a mediator of biliary tract injury and could play a role in regulation of bile duct proliferation. C57BL/6 mice underwent surgical ligation of the common bile duct. Northern blot analysis revealed a time-dependent induction of MIC-1/GDF-15 mRNA in the liver. In situ hybridization of liver sections for MIC-1/GDF-15 expression after bile duct ligation demonstrated a zone 1 or periportal expression pattern, consistent with expression of MIC-1 in periductular hepatocytes. Northern blot analysis of liver mRNA from patients with sclerosing cholangitis or cirrhosis also demonstrated enhanced expression of MIC-1/GDF-15. MIC-1/GDF-15 is expressed after bile duct injury in mice and humans. Taken together with the previously demonstrated growth inhibitory effects of MIC-1/GDF-15 on normal and transformed cells, MIC-1/GDF-15 may play a role in regulation of bile duct proliferation and biliary tumor formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592665     DOI: 10.1007/s11605-003-0037-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Profile of gene expression regulated by induced p53: connection to the TGF-beta family.

Authors:  K Kannan; N Amariglio; G Rechavi; D Givol
Journal:  FEBS Lett       Date:  2000-03-17       Impact factor: 4.124

2.  Transient down-regulation of inhibin-betaC expression following partial hepatectomy.

Authors:  A F Esquela; T A Zimmers; L G Koniaris; J V Sitzmann; S J Lee
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

3.  Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression.

Authors:  P X Li; J Wong; A Ayed; D Ngo; A M Brade; C Arrowsmith; R C Austin; H J Klamut
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

4.  Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration.

Authors:  L G Koniaris; T Zimmers-Koniaris; E C Hsiao; K Chavin; J V Sitzmann; J M Farber
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family.

Authors:  V M Paralkar; A L Vail; W A Grasser; T A Brown; H Xu; S Vukicevic; H Z Ke; H Qi; T A Owen; D D Thompson
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

Review 6.  GDF-15/MIC-1 a novel member of the TGF-beta superfamily.

Authors:  J Strelau; M Böttner; P Lingor; C Suter-Crazzolara; D Galter; J Jaszai; A Sullivan; A Schober; K Krieglstein; K Unsicker
Journal:  J Neural Transm Suppl       Date:  2000

Review 7.  Tumor suppressor activity of the TGF-beta pathway in human cancers.

Authors:  S D Markowitz; A B Roberts
Journal:  Cytokine Growth Factor Rev       Date:  1996-06       Impact factor: 7.638

8.  Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene.

Authors:  Seung Joon Baek; Leigh C Wilson; Chang-Ho Lee; Thomas E Eling
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

9.  Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study.

Authors:  David A Brown; Samuel N Breit; Julie Buring; W Douglas Fairlie; Asne R Bauskin; Tao Liu; Paul M Ridker
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

10.  Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia.

Authors:  A H Schulick; A J Taylor; W Zuo; C B Qiu; G Dong; R N Woodward; R Agah; A B Roberts; R Virmani; D A Dichek
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more
  7 in total

1.  Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.

Authors:  Jasmin Barman-Aksoezen; Domenico Girelli; Caterina Aurizi; Xiaoye Schneider-Yin; Natascia Campostrini; Luca Barbieri; Elisabeth I Minder; Gianfranco Biolcati
Journal:  J Inherit Metab Dis       Date:  2017-02-09       Impact factor: 4.982

2.  Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer.

Authors:  Teresa A Zimmers; Juan C Gutierrez; Leonidas G Koniaris
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-27       Impact factor: 4.553

3.  Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis.

Authors:  Teresa A Zimmers; Xiaoling Jin; Juan C Gutierrez; Cary Acosta; Iain H McKillop; Robert H Pierce; Leonidas G Koniaris
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-22       Impact factor: 4.553

4.  GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.

Authors:  Nils Nickel; Danny Jonigk; Tibor Kempf; Clemens L Bockmeyer; Lavinia Maegel; Johanna Rische; Florian Laenger; Ulrich Lehmann; Clemens Sauer; Mark Greer; Tobias Welte; Marius M Hoeper; Heiko A Golpon
Journal:  Respir Res       Date:  2011-05-06

5.  Clinical usefulness and acceleratory effect of macrophage inhibitory cytokine-1 on biliary tract cancer: an experimental biomarker analysis.

Authors:  Mitsuru Sugimoto; Rei Suzuki; Yoshihiro Nozawa; Tadayuki Takagi; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Ryoichiro Kobashi; Osamu Suzuki; Yuko Hashimoto; Takuto Hikichi; Hiromasa Ohira
Journal:  Cancer Cell Int       Date:  2022-08-10       Impact factor: 6.429

Review 6.  Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review.

Authors:  Mattia Bellan; Luigi Mario Castello; Mario Pirisi
Journal:  J Clin Transl Hepatol       Date:  2018-07-02

7.  Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis.

Authors:  Zhanyi Li; Yu Liu; Xiangyong Li; Yuankai Wu; Fangji Yang; Qiwan Mo; Yutian Chong
Journal:  Biomed Res Int       Date:  2020-10-29       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.